Wasatch Advisors Inc Sangamo Therapeutics, Inc Transaction History
Wasatch Advisors Inc
- $17.6 Billion
- Q1 2025
A detailed history of Wasatch Advisors Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 6,868,766 shares of SGMO stock, worth $3.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,868,766
Previous 9,231,505
25.59%
Holding current value
$3.09 Million
Previous $9.42 Million
51.86%
% of portfolio
0.03%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
51.2MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.12 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.03 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2MShares$899,1190.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $70.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...